Human mesothelioma cell lines developed from malignant pleural effusions as tools to develop novel therapies and guide personalised medicine
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
BMJ Publishing Group
2018
|